Dyne Therapeutics's total assets for Q2 2025 were $728.99M, an increase of 1.10% from the previous quarter. DYN total liabilities were $157.55M for the fiscal quarter, a 202.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.